Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.

Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA as the measure of average blood glucose levels for the 3 months preceding the HbA test date. The use of this measure highlights the long-established correlation between HbA and relative risk of diabetes complications; the change in the measure, before and after the therapeutic intervention, is used by regulators for the approval of medications for diabetes. However, with the increasing use of continuous glucose monitoring (CGM) in clinical practice, prospective clinical studies are also increasingly using CGM devices to collect data and evaluate glucose profiles among study participants, complementing HbA findings, and further assess the effects of therapeutic interventions on HbA.

Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12-week randomized controlled trial.

Aims: To evaluate whether there is a difference between the effects of dapagliflozin and gliclazide modified release (MR) on glycaemic variability (GV) and glycaemic control, as assessed by continuous glucose monitoring (CGM), in individuals with uncontrolled type 2 diabetes.

Materials And Methods: This randomized, open-label, active-controlled study was conducted in individuals with uncontrolled type 2 diabetes who were drug-naïve or on steady-dose metformin monotherapy. Participants were treated once daily with 10 mg dapagliflozin or 120 mg gliclazide MR.

International Consensus on Use of Continuous Glucose Monitoring.

Measurement of glycated hemoglobin (HbA) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA testing and self-monitoring of blood glucose.

Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge.

Aims: To demonstrate whether young people with T1D using modern insulin treatment and CGM could successfully participate in extreme sport activity while maintaining good glycemic control.

Methods: The challenge took place in Crete/Greece over 4 days combining a long-distance trek of different levels of severity with final destination the summit of the White Mountains at 2080 m. Eleven participants (5/6 female/male, age 18.

Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry.

Background: Intensified insulin delivery using multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) is recommended in children with type 1 diabetes (T1D) to achieve good metabolic control.

Objective: To examine the frequency of pump usage in T1D children treated in SWEET (Better control in Paediatric and Adolescent diabeteS: Working to crEate CEnTers of Reference) centers and to compare metabolic control between patients treated with CSII vs MDI.

Methods: This study included 16 570 T1D children participating in the SWEET prospective, multicenter, standardized diabetes patient registry.

A new method of microvolume back-extraction procedure for enrichment of Pb and Cd and determination by flame atomic absorption spectrometry.

The need for highly reliable methods for the determination of trace elements has been recognised in analytical chemistry and environmental science. A method for the trace analysis of Pb and Cd in natural waters is described. In a preconcentration step, 500 ml of an aqueous sample containing lead and cadmium were extracted into 3.

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion.

Introduction: Familial renal glucosuria (FRG) is a rare renal tubular disorder caused by mutations within the SLC5A2 gene. It is characterized by persistent glucosuria in the absence of hyperglycaemia and any other signs of generalized tubular dysfunction. In small series of patients previously reported, the molecular and phenotypic findings in FRG families, including first hints of extracellular volume depletion and activation of the renin-angiotensin-aldosterone system induced by natriuresis, have been described.

The application of catalase for the elimination of hydrogen peroxide residues after bleaching of cotton fabrics.

Results of dyeing of cotton fabrics with a bifunctional reactive dye were significantly improved when the fabric after bleaching with hydrogen peroxide was treated with catalase for the elimination of hydrogen peroxide residues from the fabrics. Compared to processes with a varying number of washing steps, with and without commercial reducing agents, the consumption of water could be significantly reduced, without altering the final color shade.